ArticleiScience2026
A deep learning framework for standardized interpretation of multiparameter cardiac ultrasound and disease classification.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Echocardiographic interpretation underlies a large share of cardiovascular diagnoses, yet specialist expertise remains unevenly distributed, and quantitative measurements show inter-observer variability of 15-17% that contributes to disagreement in borderline cases. We developed DeepCard, a multi-task deep learning system that produces standardized, reproducible interpretation of pre-measured echocardiographic parameters by jointly analyzing 39 quantitative measurements across 17 diagnostic tasks spanning valvular disease, ventricular dysfunction, and structural abnormalities. Trained on 400 patients, DeepCard reached 91% specificity for valvular assessment and 82% accuracy for ventricular evaluation, and reduced inter-observer interpretive variability for pre-measured parameters to 13.4%. On an independent external cohort of 102 patients from a separate institution, performance decreased by only 2.6%, indicating consistent generalization. By providing standardized interpretation of quantitative measurements, DeepCard may help clinicians achieve more consistent and reproducible cardiac assessment, particularly in settings where specialist availability is limited.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.